The total return over the past 12 months is +57.75% vs. +16.94% for the S&P 500. So far it's up -17.41% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +57.75% | (18.88%) | (22.14%) | (29.77%) | N/A | N/A |
| Total Return CAGR | +57.75% | (18.88%) | (22.14%) | (29.77%) | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Minerva Neurosciences, Inc. (NERV)
| Year | Start price | End price | NERV Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $4.02 | $3.32 | (17.41%) | +14.51% | (31.92%) |
| 2025 | $2.22 | $4.02 | +81.08% | +17.72% | +63.36% |
| 2024 | $6.15 | $2.22 | (63.90%) | +24.89% | (88.79%) |
| 2023 | $1.59 | $6.15 | +286.79% | +26.19% | +260.60% |
| 2022 | $6.41 | $1.59 | (75.20%) | (18.17%) | (57.03%) |
| 2021 | $18.72 | $6.41 | (65.76%) | +28.74% | (94.50%) |
| 2020 | $56.88 | $18.72 | (67.09%) | +18.37% | (85.46%) |
| 2019 | $53.92 | $56.88 | +5.49% | +31.22% | (25.73%) |
| 2018 | $48.40 | $53.92 | +11.40% | (4.56%) | +15.96% |
| 2017 | $94.00 | $48.40 | (48.51%) | +21.70% | (70.21%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
